The FDA approved Addyi (flibanserin), a libido-enhancing drug, in postmenopausal women under the age of 65. Experts explain ...
An FDA panel of experts has called for a loosening of regulations and expanding access to testosterone replacement therapy.
The "little pink pill" is now available to even more women. The Food and Drug Administration (FDA) just approved Addyi for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback